Status:
WITHDRAWN
Waitlist-Control Trial of Smartphone CBT for Obsessive-Compulsive Disorder (OCD)
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
Telefónica S.A.
Conditions:
Obsessive-Compulsive Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators are testing the efficacy of Smartphone-delivered cognitive behavioral therapy (CBT) treatment for obsessive compulsive disorder (OCD). The investigators hypothesize that participants...
Detailed Description
The primary aims of this study are to test the efficacy of a Smartphone-based CBT treatment for adults with OCD recruited nationally. Eligible subjects (N=58) will be randomly assigned to 12 weeks of ...
Eligibility Criteria
Inclusion
- at least 18 years of age
- current diagnosis of primary DSM-5 OCD, based on MINI
- currently living in the United States
Exclusion
- Psychotropic medication changes within 2 months prior to enrollment (Participants taking psychotropic medication must have been on a stable dose for at least 2 months prior to enrollment and not change medication during study period)
- Past participation in ≥ 4 sessions of CBT for OCD
- Current severe substance use disorder
- Lifetime bipolar disorder or psychosis
- Acute, active suicidal ideation as indicated by clinical judgment and/or a score ≥ 2 on the suicidal ideation subscale of the C-SSRS
- Current severe comorbid major depression, as indicated by clinical judgment and/or a QIDS-SR total score ≥ 21
- Concurrent psychological treatment
- Does not own a supported mobile Smartphone with a data plan
- Lack of technology literacy that would interfere with ability to engage with smartphone treatment
Key Trial Info
Start Date :
July 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03767491
Start Date
July 1 2019
End Date
June 1 2022
Last Update
August 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Anna Schwartzberg
Boston, Massachusetts, United States, 02114